Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...
Edgewise Therapeutics: More Expensive Now, But Much More Derisked
Edgewise Therapeutics' stock soars on positive Becker Muscular Dystrophy trial results. Learn why EWTX is a promising buy with derisked programs.
Family of Rubie Boyton who suffered brain damage after collapsing in Ashford play park transferred to Kent hospital after nine months at King’s College Hospital in Lon…
The family of a young girl left brain-damaged after collapsing just days after her 16th birthday hope she will be back home ...